Monitoring the quality of life in patients with coronary artery disease☆
References (20)
- et al.
Measuring change over time: assessing the usefulness of evaluative instruments
J Chronic Dis
(1987) - et al.
Relation of clinical and angiographic factors to functional capacity as measured by the Duke activity status index
Am J Cardiol
(1991) - et al.
Regression of CAD as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
N Engl J Med
(1990) - et al.
Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerotic Regression Study (MARS)
Ann Intern Med
(1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
N Engl J Med
(1993)Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
Lancet
(1988)- et al.
Pre-hospital-initiated vs hospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention trial
JAMA
(1993) GIS-SI-2: a factorial randomised trial of alteplase versus streptokinase and heparin ver-sus no heparin among 12,490 patients with acute myocardial infarction
Lancet
(1990)- et al.
An approach to evaluating thrombolytic therapy in acute myocardial infarction: the unsatisfactory endpoint
Circulation
(1992) - et al.
Measuring health-related quality of life
Ann Intern Med
(1993)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
This research was supported by HSR&D Project IIR #93133R and CSHS #7 from the Department of Veterans' Affairs, Veterans' Health Administration, Health Services Research and Development Service, Seattle, Washington.
- 1
Dr. Spertus was a Health Services Research and Development fellow at the Seattle Veterans' Affairs Medical Center.
Copyright © 1994 Published by Elsevier Inc.